{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:11:30Z","timestamp":1790946690479,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003947","name":"Universidad Nacional de La Plata","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ymgme.2020.06.003","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T21:01:45Z","timestamp":1591650105000},"page":"274-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Gaucher disease-associated alterations in mesenchymal stem cells reduce osteogenesis and favour adipogenesis processes with concomitant increased osteoclastogenesis"],"prefix":"10.1016","volume":"130","author":[{"given":"A.","family":"Crivaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bondar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Mucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ormazabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.V.","family":"Delpino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"Rozenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ymgme.2020.06.003_bb0005","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1172\/JCI105417","article-title":"Demonstration of a deficiency of Glucocerebroside-cleaving enzyme in Gaucher\u2019s disease","volume":"45","author":"R 0","year":"1966","journal-title":"J. Clin. Invest."},{"issue":"16","key":"10.1016\/j.ymgme.2020.06.003_bb0010","first-page":"118","article-title":"Elevated plasma glucosylsphingosine in Gaucher disease\u202f: relation to phenotype, storage cell markers, and therapeutic response","volume":"118","author":"Dekker","year":"2015"},{"issue":"2","key":"10.1016\/j.ymgme.2020.06.003_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020441","article-title":"A review of Gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2020.06.003_bb0020","first-page":"299","article-title":"Gaucher disease: clinical profile and therapeutic developments","volume":"4","author":"Cox","year":"2010","journal-title":"Biologics."},{"issue":"9645","key":"10.1016\/j.ymgme.2020.06.003_bb0025","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher\u2019s disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet (London, England)."},{"issue":"2","key":"10.1016\/j.ymgme.2020.06.003_bb0030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/17446651.2018.1445524","article-title":"Recent advances in the diagnosis and management of Gaucher disease HHS Public Access","volume":"13","author":"Gary","year":"2018","journal-title":"Expert. Rev. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2020.06.003_bb0035","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/jbmr.3734","article-title":"Gaucher disease in bone: from pathophysiology to practice","volume":"34","author":"Hughes","year":"2019","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.ymgme.2020.06.003_bb0040","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/00016470410004003","article-title":"Orthopedic considerations in Gaucher disease since the advent of enzyme replacement therapy","volume":"75","author":"Itzchaki","year":"2004","journal-title":"Acta Orthop. Scand."},{"issue":"1","key":"10.1016\/j.ymgme.2020.06.003_bb0045","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/MD.0b013e3182057be4","article-title":"Osseous manifestations of adult gaucher disease in the era of enzyme replacement therapy","volume":"90","author":"Deegan","year":"2011","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.ymgme.2020.06.003_bb0050","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ymgme.2011.08.004","article-title":"Therapeutic approaches to bone pathology in Gaucher disease: past, present and future","volume":"104","author":"Goker-Alpan","year":"2011","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2020.06.003_bb0055","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1152\/physrev.00036.2016","article-title":"Osteoimmunology: the conceptual framework unifying the immune and skeletal systems","volume":"97","author":"Okamoto","year":"2017","journal-title":"Physiol. Rev."},{"issue":"45","key":"10.1016\/j.ymgme.2020.06.003_bb0060","doi-asserted-by":"crossref","first-page":"19473","DOI":"10.1073\/pnas.1003308107","article-title":"Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage","volume":"107","author":"Mistry","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.ymgme.2020.06.003_bb0065","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/hmg\/ddu538","article-title":"Glucocerebrosidase deficiency in zebrafish affects primary bone ossification through increased oxidative stress and reduced Wnt\/\u03b2-catenin signaling","volume":"24","author":"Zancan","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.ymgme.2020.06.003_bb0070","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/hmg\/ddx442","article-title":"Gaucher disease iPSC-derived osteoblasts have developmental and lysosomal defects that impair bone matrix deposition","volume":"27","author":"Panicker","year":"2018","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.ymgme.2020.06.003_bb0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bcmd.2013.04.006","article-title":"Enhanced differentiation of osteoclasts from mononuclear precursors in patients with Gaucher disease","volume":"51","author":"Reed","year":"2013","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2020.06.003_bb0080","series-title":"Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease","author":"Bondar","year":"2017"},{"issue":"2","key":"10.1016\/j.ymgme.2020.06.003_bb0085","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.gene.2013.09.072","article-title":"Uncoupling of osteoblast\u2013osteoclast regulation in a chemical murine model of Gaucher disease","volume":"532","author":"Mucci","year":"2013","journal-title":"Gene."},{"key":"10.1016\/j.ymgme.2020.06.003_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/S0083-6729(06)74015-8","article-title":"Regulation of Osteoclast Differentiation and Function by Interleukin-1","author":"Nakamura","year":"2006","journal-title":"Vitam. Horm."},{"issue":"3","key":"10.1016\/j.ymgme.2020.06.003_bb0095","first-page":"1862","article-title":"The mechanism of Osteoclast differentiation induced by IL-1","volume":"183","author":"Kim","year":"2009"},{"issue":"6","key":"10.1016\/j.ymgme.2020.06.003_bb0100","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The Inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell."},{"issue":"4","key":"10.1016\/j.ymgme.2020.06.003_bb0105","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ni.2228","article-title":"A role for the NLRP3 inflammasome in metabolic diseases\u2014did Warburg miss inflammation","volume":"13","author":"Wen","year":"2012","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.ymgme.2020.06.003_bb0110","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1073\/pnas.0712145105","article-title":"A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy","volume":"105","author":"Lee","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.ymgme.2020.06.003_bb0115","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.bbrc.2017.02.007","article-title":"NLRP3 inflammasome activation in mesenchymal stem cells inhibits osteogenic differentiation and enhances adipogenic differentiation","volume":"484","author":"Wang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.ymgme.2020.06.003_bb0120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cmet.2009.02.006","article-title":"Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic Steatosis and inflammation","volume":"9","author":"Purushotham","year":"2009","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2020.06.003_bb0125","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/emmm.201201606","article-title":"SIRT1 regulates differentiation of mesenchymal stem cells by deacetylating \u03b2-catenin","volume":"5","author":"Simic","year":"2013","journal-title":"EMBO Mol Med."},{"issue":"5","key":"10.1016\/j.ymgme.2020.06.003_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178520","article-title":"SIRT1 is a positive regulator of the master osteoblast transcription factor, RUNX2","volume":"12","author":"Zainabadi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2020.06.003_bb0135","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bone.2017.12.014","article-title":"Is fatty acid composition of human bone marrow significant to bone health?","volume":"118","author":"Pino","year":"2017","journal-title":"Bone."},{"issue":"2","key":"10.1016\/j.ymgme.2020.06.003_bb0140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1615\/CritRevEukarGeneExpr.v19.i2.20","article-title":"Marrow fat and the bone microenvironment: developmental, functional, and pathological implications","volume":"19","author":"Rosen","year":"2009","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.ymgme.2020.06.003_bb0145","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bone.2014.06.014","article-title":"Marrow fat composition in anorexia nervosa","volume":"66","author":"Bredella","year":"2014","journal-title":"Bone."},{"issue":"5411","key":"10.1016\/j.ymgme.2020.06.003_bb0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science."},{"issue":"1","key":"10.1016\/j.ymgme.2020.06.003_bb0155","first-page":"4","article-title":"The mechanism of mineralization and the role of Alkaline Phosphatase in health and disease","volume":"77","author":"Orimo","year":"2010"},{"issue":"25","key":"10.1016\/j.ymgme.2020.06.003_bb0160","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1093\/nar\/22.25.5628","article-title":"Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha","volume":"22","author":"Tontonoz","year":"1994","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.ymgme.2020.06.003_bb0165","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1006\/bbrc.2000.2981","article-title":"Multilineage differentiation of Cbfa1-deficient calvarial cells in vitro","volume":"273","author":"Kobayashi","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.ymgme.2020.06.003_bb0170","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.5966\/sctm.2015-0311","article-title":"Human induced pluripotent stem cells differentiate into functional mesenchymal stem cells and repair bone defects","volume":"5","author":"Sheyn","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ymgme.2020.06.003_bb0175","doi-asserted-by":"crossref","first-page":"104647","DOI":"10.1016\/j.nbd.2019.104647","article-title":"A characterization of Gaucher iPS-derived astrocytes: potential implications for Parkinson\u2019s disease","volume":"134","author":"Aflaki","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2020.06.003_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118771","article-title":"Properties of neurons derived from induced pluripotent stem cells of Gaucher disease type 2 patient fibroblasts: potential role in neuropathology","volume":"10","author":"Sun","year":"2015","journal-title":"PLoS One"},{"issue":"44","key":"10.1016\/j.ymgme.2020.06.003_bb0185","doi-asserted-by":"crossref","first-page":"18054","DOI":"10.1073\/pnas.1207889109","article-title":"Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease","volume":"109","author":"Panicker","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.ymgme.2020.06.003_bb0190","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/stem.1732","article-title":"Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development","volume":"32","author":"Panicker","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.ymgme.2020.06.003_bb0195","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.imbio.2016.11.002","article-title":"Negative regulation of NLRP3 inflammasome by SIRT1 in vascular endothelial cells","volume":"222","author":"Li","year":"2017","journal-title":"Immunobiology."},{"key":"10.1016\/j.ymgme.2020.06.003_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2008.10.054","article-title":"The gene-expression and phenotypic response of hFOB 1.19 osteoblasts to surface-modified titanium and zirconia","volume":"30","author":"Setzer","year":"2009","journal-title":"Biomaterials."},{"issue":"24","key":"10.1016\/j.ymgme.2020.06.003_bb0205","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1038\/sj.onc.1207676","article-title":"Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression","volume":"23","author":"Stein","year":"2004","journal-title":"Oncogene."},{"issue":"2","key":"10.1016\/j.ymgme.2020.06.003_bb0210","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell."},{"issue":"3","key":"10.1016\/j.ymgme.2020.06.003_bb0215","first-page":"502","article-title":"The effect of biologic agents on bone homeostasis in chronic inflammatory rheumatic diseases","volume":"37","author":"Di Munno","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.ymgme.2020.06.003_bb0220","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3389\/fimmu.2014.00511","article-title":"Biology of the RANKL-RANK-OPG system in immunity, bone, and Beyond","volume":"5","author":"Walsh","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymgme.2020.06.003_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069293","article-title":"A prospective study of bone marrow hematopoietic and mesenchymal stem cells in type 1 Gaucher disease patients","author":"Lecourt","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ymgme.2020.06.003_bb0230","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00223-001-2072-0","article-title":"Bone marker alterations in patients with type 1 Gaucher disease","volume":"72","author":"Ciana","year":"2003","journal-title":"Calcif. Tissue Int."},{"issue":"4","key":"10.1016\/j.ymgme.2020.06.003_bb0235","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4081\/hr.2012.e21","article-title":"Bone turnover markers in patients with type 1 Gaucher disease","volume":"4","author":"Giuffrida","year":"2012","journal-title":"Hematol. Rep."},{"issue":"2","key":"10.1016\/j.ymgme.2020.06.003_bb0240","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ajh.24957","article-title":"Demographics and patient characteristics of 1209 patients with Gaucher disease: descriptive analysis from the Gaucher outcome survey (GOS)","volume":"93","author":"Zimran","year":"2018","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.ymgme.2020.06.003_bb0245","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0004563218759371","article-title":"The bone remodelling cycle","volume":"55","author":"Kenkre","year":"2018","journal-title":"Ann Clin Biochem Int J Lab Med."},{"issue":"4","key":"10.1016\/j.ymgme.2020.06.003_bb0250","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/0022034514522485","article-title":"IL-6 alters osteocyte signaling toward osteoblasts but not osteoclasts","volume":"93","author":"Bakker a","year":"2014","journal-title":"J. Dent. Res."},{"issue":"3","key":"10.1016\/j.ymgme.2020.06.003_bb0255","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejmhg.2015.02.001","article-title":"Cytokines in Gaucher disease: role in the pathogenesis of bone and pulmonary disease","volume":"16","author":"Tantawy","year":"2015","journal-title":"Egypt J Med Hum Genet."},{"issue":"5","key":"10.1016\/j.ymgme.2020.06.003_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217780","article-title":"Efficacy of pentosan polysulfate in in vitro models of lysosomal storage disorders: Fabry and Gaucher disease","volume":"14","author":"Crivaro","year":"2019","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.ymgme.2020.06.003_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ymgme.2020.06.003_bb0270","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cmet.2013.09.010","article-title":"Canonical Nlrp3 Inflammasome links systemic low-grade inflammation to functional decline in aging","volume":"18","author":"Youm","year":"2013","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2020.06.003_bb0275","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1096\/fj.201901437R","article-title":"Glucosylceramide synthase regulates adipo-osteogenic differentiation through synergistic activation of PPAR\u03b3 with GlcCer","volume":"34","author":"Jang","year":"2020","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.ymgme.2020.06.003_bb0280","doi-asserted-by":"crossref","first-page":"514","DOI":"10.14336\/AD.2015.1206","article-title":"The role of bone marrow microenvironment in governing the balance between Osteoblastogenesis and Adipogenesis","volume":"7","author":"Li","year":"2016","journal-title":"Aging Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2020.06.003_bb0285","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2220\/biomedres.35.153","article-title":"Potentiation of osteoclastogenesis by adipogenic conversion of bone marrow- derived mesenchymal stem cells","volume":"35","author":"Mori","year":"2014","journal-title":"Biomed. Res."},{"issue":"15","key":"10.1016\/j.ymgme.2020.06.003_bb0290","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1182\/blood-2009-02-205708","article-title":"Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome","volume":"114","author":"Campeau","year":"2009","journal-title":"Blood."},{"issue":"6","key":"10.1016\/j.ymgme.2020.06.003_bb0295","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1006\/bcmd.2001.0474","article-title":"Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease","volume":"27","author":"Hollak","year":"2001","journal-title":"Blood Cells Mol. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2020.06.003_bb0300","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bcmd.2012.11.001","article-title":"Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease","volume":"50","author":"van Dussen","year":"2013","journal-title":"Blood Cells Mol. Dis."}],"updated-by":[{"DOI":"10.1016\/j.ymgme.2020.07.003","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000}}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220301426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220301426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:25:08Z","timestamp":1761089108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719220301426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1096719220301426"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.06.003","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gaucher disease-associated alterations in mesenchymal stem cells reduce osteogenesis and favour adipogenesis processes with concomitant increased osteoclastogenesis","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}